Results
|
|
6981.
|
Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats. [electronic resource] by
- Arimori, Kazuhiko
- Kuroki, Noriaki
- Hidaka, Muneaki
- Iwakiri, Tomomi
- Yamsaki, Keishi
- Okumura, Manabu
- Ono, Hiroshige
- Takamura, Norito
- Kikuchi, Masahiko
- Nakano, Masahiro
Producer: 20040220
In:
Pharmaceutical research vol. 20
Availability: No items available.
|
|
|
6982.
|
|
|
|
6983.
|
|
|
|
6984.
|
|
|
|
6985.
|
|
|
|
6986.
|
|
|
|
6987.
|
An open-label, single-arm, phase 2 trial of panitumumab plus FOLFIRI as second-line therapy in patients with metastatic colorectal cancer. [electronic resource] by
- Cohn, Allen L
- Shumaker, Grace C
- Khandelwal, Pankaj
- Smith, David A
- Neubauer, Marcus A
- Mehta, Nilesh
- Richards, Donald
- Watkins, David L
- Zhang, Kathy
- Yassine, Mohamed R
Producer: 20111208
In:
Clinical colorectal cancer vol. 10
Availability: No items available.
|
|
|
6988.
|
|
|
|
6989.
|
|
|
|
6990.
|
Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience. [electronic resource] by
- Wolf, Patrick S
- Park, James O
- Bao, Fei
- Allen, Peter J
- DeMatteo, Ronald P
- Fong, Yuman
- Jarnagin, William R
- Kingham, T Peter
- Gönen, Mithat
- Kemeny, Nancy
- Shia, Jinru
- D'Angelica, Michael I
Producer: 20130221
In:
Journal of the American College of Surgeons vol. 216
Availability: No items available.
|
|
|
6991.
|
|
|
|
6992.
|
|
|
|
6993.
|
Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for wild-type KRAS metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines. [electronic resource] by
- Shitara, Kohei
- Yuki, Satoshi
- Yoshida, Motoki
- Takahari, Daisuke
- Utsunomiya, Setsuo
- Yokota, Tomoya
- Sato, Yozo
- Inaba, Yoshitaka
- Tajika, Masahiro
- Kawai, Hiroki
- Yamaura, Hidekazu
- Kato, Mina
- Yamazaki, Kentaro
- Komatsu, Yoshito
- Muro, Kei
Producer: 20120611
In:
Investigational new drugs vol. 30
Availability: No items available.
|
|
|
6994.
|
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab. [electronic resource] by
- Giampieri, Riccardo
- Mandolesi, Alessandra
- Abouelkhair, Khaled M
- Loretelli, Cristian
- Del Prete, Michela
- Faloppi, Luca
- Maristella, Bianconi
- Ibrahim, Ezzeldin M
- Scarpelli, Marina
- Cascinu, Stefano
- Scartozzi, Mario
Producer: 20160419
In:
Journal of translational medicine vol. 13
Availability: No items available.
|
|
|
6995.
|
Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience. [electronic resource] by
- Jin, Zhaohui
- Hartgers, Mindy L
- Sanhueza, Cristobal T
- Shubert, Christopher R
- Alberts, Steven R
- Truty, Mark J
- Muppa, Prasuna
- Nagorney, David M
- Smyrk, Thomas C
- Hassan, Mohamed
- Mahipal, Amit
Producer: 20180620
In:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology vol. 44
Availability: No items available.
|
|
|
6996.
|
|
|
|
6997.
|
|
|
|
6998.
|
Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor. [electronic resource] by
- Miknyoczki, Sheila J
- Jones-Bolin, Susan
- Pritchard, Sonya
- Hunter, Kathryn
- Zhao, Hugh
- Wan, Weihua
- Ator, Mark
- Bihovsky, Ronald
- Hudkins, Robert
- Chatterjee, Sankar
- Klein-Szanto, Andres
- Dionne, Craig
- Ruggeri, Bruce
Producer: 20040206
In:
Molecular cancer therapeutics vol. 2
Availability: No items available.
|
|
|
6999.
|
|
|
|
7000.
|
|